ClinConnect ClinConnect Logo
Search / Trial NCT03396458

Hepatitis B Prevalence in the Turkish Population Living in Middle Limburg

Launched by HASSELT UNIVERSITY · Jan 9, 2018

Trial Information

Current as of July 21, 2025

Unknown status

Keywords

Hepatitis B Disease Prevalence Screening Migrant Turkish Belgium

ClinConnect Summary

HBV infection is an important public health problem in the Turkish population, i.e. one of the largest migrant populations in Europe. With the introduction of cost-effective antiviral treatments in the past decade, there is a need to identify HBV infected patients who may benefit from treatment. This study will assess the HBV prevalence in the Turkish population living in Belgium. Additionally, the investigators will determine the risk factors of HBV infection and the uptake of screening, vaccination and antiviral treatment in this hard-to-reach Turkish population.

A cross-sectional, epide...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Turkish origin, defined as one of the parents born in Turkey
  • Having a signed informed consent form
  • Exclusion Criteria:
  • /

About Hasselt University

Hasselt University is a prestigious research institution located in Belgium, renowned for its commitment to advancing scientific knowledge and innovation. With a strong focus on interdisciplinary research, the university actively engages in clinical trials that aim to address pressing health challenges. Leveraging a robust network of collaborations with healthcare professionals, industry partners, and research organizations, Hasselt University strives to translate research findings into practical applications that benefit patient care and public health. The institution is dedicated to maintaining the highest ethical standards and regulatory compliance in all its clinical research endeavors.

Locations

Genk, Limburg, Belgium

Patients applied

0 patients applied

Trial Officials

Geert Robaeys, M.D., Ph.D.

Principal Investigator

Hasselt University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials